Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Isolated hepatic localizations of neuroendocrine tumors (NETs) are generally considered as metastatic NETs of unknown primary but could correspond to primary hepatic NETs (PHNETs), a poorly explored entity.
Conference:
Presenting Author:
Authors: de Mestier L, Nicolle R, Poté N, Rebours V, Hentic O,
Keywords: liver, unknown primary, DNA sequencing, RNA sequencing, immunohistochemistry,
#3361 FOLFOX-bevacizumab chemotherapy in patients with progressive metastatic neuroendocrine tumors
Introduction: Well-differentiated neuroendocrine tumors (NETs) are relatively rare, highly vascularized neoplasms. Antiangiogenic drugs have shown efficacy in patients with advanced NETs. Bevacizumab is a well-known antiangiogenic monoclonal antibody.
Conference:
Presenting Author:
Authors: Lacombe C, Perrier M, Hentic O, Brixi H, Rebours V,
Keywords: neuroendocrine tumor, antiangiogenic therapy, VEGF, well-differentiated,
#1900 Well-Differentiated G1/G2 Pancreatic NETs Can Evolve Towards G3 Tumors
Introduction: Well-differentiated G1/G2 pancreatic NET (pNET) may evolve towards well-differentiated G3 pNET or carcinoma (pNEC)
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Olivia H
Authors: Hentic O, Cros J, Rebours V, Zappa M, Muller N,
Keywords: dedifferentiation, new biopsy,
Introduction: The 18F-FDG uptake assessed by PET/CT is correlated to prognosis in most tumors.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Bucau M, Laurent-Bellue A, Cros J, Hentic O, Rebours V,
Keywords: Neuroendocrine tumors, PET-scan, 18-FDG, Ki67, VHL, metabolism,
Introduction: Patients with PNET might benefit from new therapeutic approaches acting on the mTOR signaling pathway. Culture of precision-cut slices could allow testing these molecules in human tumors, allowing personalized treatments.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Bucau M, Cros J, Rebours V, Albuquerque M, Paradis V,
Keywords: pancreas, targeted therapies, tissue culture, neuroendocrine tumors,